| |
Latest 10 SEC filings (by transaction date) for PBH within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 5/24 | Mar 1/24 | Fritz Mary Beth | Direct Ownership | Employee Stock Options (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -110 | |
Mar 5/24 | Mar 1/24 | Fritz Mary Beth | Direct Ownership | Employee Stock Options (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -62 | |
Mar 5/24 | Mar 1/24 | Fritz Mary Beth | Direct Ownership | Common Stock, par value $0.01 per share | S - Open market or private sale | -110 | $70.41 |
Mar 5/24 | Mar 1/24 | Fritz Mary Beth | Direct Ownership | Common Stock, par value $0.01 per share | M - Exercise or conversion exempt under rule 16b-3 | 110 | $30.56 |
Mar 5/24 | Mar 1/24 | Fritz Mary Beth | Direct Ownership | Common Stock, par value $0.01 per share | S - Open market or private sale | -62 | $70.43 |
Mar 5/24 | Mar 1/24 | Fritz Mary Beth | Direct Ownership | Common Stock, par value $0.01 per share | M - Exercise or conversion exempt under rule 16b-3 | 62 | $57.18 |
Feb 29/24 | Feb 28/24 | Fritz Mary Beth | Direct Ownership | Employee Stock Options (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -416 | |
Feb 29/24 | Feb 28/24 | Fritz Mary Beth | Direct Ownership | Employee Stock Options (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -246 | |
Feb 29/24 | Feb 28/24 | Fritz Mary Beth | Direct Ownership | Common Stock, par value $0.01 per share | S - Open market or private sale | -416 | $70.36 |
Feb 29/24 | Feb 28/24 | Fritz Mary Beth | Direct Ownership | Common Stock, par value $0.01 per share | M - Exercise or conversion exempt under rule 16b-3 | 416 | $30.56 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for PBH within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 5/24 | Mar 1/24 | Fritz Mary Beth | Direct Ownership | Employee Stock Options (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -110 | |
Mar 5/24 | Mar 1/24 | Fritz Mary Beth | Direct Ownership | Employee Stock Options (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -62 | |
Mar 5/24 | Mar 1/24 | Fritz Mary Beth | Direct Ownership | Common Stock, par value $0.01 per share | S - Open market or private sale | -110 | $70.41 |
Mar 5/24 | Mar 1/24 | Fritz Mary Beth | Direct Ownership | Common Stock, par value $0.01 per share | M - Exercise or conversion exempt under rule 16b-3 | 110 | $30.56 |
Mar 5/24 | Mar 1/24 | Fritz Mary Beth | Direct Ownership | Common Stock, par value $0.01 per share | S - Open market or private sale | -62 | $70.43 |
Mar 5/24 | Mar 1/24 | Fritz Mary Beth | Direct Ownership | Common Stock, par value $0.01 per share | M - Exercise or conversion exempt under rule 16b-3 | 62 | $57.18 |
Feb 29/24 | Feb 28/24 | Fritz Mary Beth | Direct Ownership | Employee Stock Options (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -416 | |
Feb 29/24 | Feb 28/24 | Fritz Mary Beth | Direct Ownership | Employee Stock Options (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -246 | |
Feb 29/24 | Feb 27/24 | Fritz Mary Beth | Direct Ownership | Employee Stock Options (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -1 | |
Feb 29/24 | Feb 28/24 | Fritz Mary Beth | Direct Ownership | Common Stock, par value $0.01 per share | S - Open market or private sale | -416 | $70.36 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Eyepoint Pharmaceuticals (OQ:EYPT) |
AbbVie (N:ABBV) |
Merck & Co (N:MRK) |